Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “MAIA PHARMACEUTICALS, INC.”

10 pharma patents match "MAIA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 10
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 10 pharmaceutical patents matching "MAIA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

10 results for “MAIA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 12005069

    Bortezomib compositions

    MAIA PHARMACEUTICALS, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  2. US 11992514

    Ready-to-use bivalirudin compositions

    MAIA PHARMACEUTICALS, INC. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  3. US 11918622

    Ready-to-use bivalirudin compositions

    MAIA PHARMACEUTICALS, INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  4. US 11903993

    Ready-to-use bivalirudin compositions

    MAIA PHARMACEUTICALS, INC. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  5. US 11752164

    Bortezomib compositions

    MAIA PHARMACEUTICALS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  6. US 11737983

    Storage stable sincalide formulations

    MAIA PHARMACEUTICALS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  7. US 11679119

    Bortezomib compositions

    MAIA PHARMACEUTICALS, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  8. US 11672813

    Bortezomib compositions

    MAIA PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  9. US 11318100

    Storage stable sincalide formulations

    MAIA PHARMACEUTICALS, INC. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted
  10. US 11110063

    Storage stable sincalide formulations

    MAIA PHARMACEUTICALS, INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted